enVVeno Medical Corp reports results for the quarter ended December 31 - Earnings Summary
28/02/2025 13:52
enVVeno Medical Corp NVNO.OQ reported a quarterly adjusted loss of 30 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -36 cents. The lone analyst forecast for the quarter was for a loss of 35 cents per share. Reported revenue was zero; analysts expected zero. enVVeno Medical Corp's reported EPS for the quarter was a loss of 30 cents. The company reported a quarterly loss of $6.23 million. enVVeno Medical Corp shares had risen by 16.9% this quarter. FORECAST CHANGES The mean earnings estimate of analysts was unchanged in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "strong buy" Wall Street's median 12-month price target for enVVeno Medical Corp is $16.50 This summary was machine generated from LSEG data February 28 at 01:52 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Dec. 31 2024 | -0.35 | -0.30 | Beat |
| Sep. 30 2024 | -0.33 | -0.35 | Missed |
| Jun. 30 2024 | -0.36 | -0.31 | Beat |
| Mar. 31 2024 | -0.40 | -0.31 | Beat |